Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome

Abstract

A higher proportion of small, dense low-density lipoprotein (sdLDL) is known to be associated with a high prevalence of cardiovascular disease in association with metabolic syndrome (MS). Hypertension (HTN) is one of the known risk factors for MS. However, whether HTN is associated with sdLDL in patients without MS is not yet clear. The lipid profiles, including low-density-lipoprotein (LDL) subfractions, of 383 consecutive subjects were evaluated. The patients without MS consisted of 198 hypertensive patients (non-MS/HTN group) and 108 normotensive subjects (non-MS/non-HTN group). The peak and mean particle diameter of LDL were measured by gradient gel electrophoresis. Plasma total cholesterol, LDL cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride (TG), HDL cholesterol/Apo A1, LDL-C/ApoB and Apo(A1, B, CII and E) levels did not differ between the non-MS/non-HTN and non-MS/HTN groups. When analyzing LDL subfraction, the absolute amount of patterns A and B was not different between the non-MS/non-HTN and non-MS/HTN groups. Compared with the non-MS/non-HTN groups, the proportion of sdLDL was higher in the non-MS/HTN group (37.7% versus 39.9%, P=0.046), but not significant after adjustment of waist circumference, serum TG, age and statin usage. The proportion of sdLDL to total LDL was higher in hypertensive subjects, even those without MS, than in normotensive subjects. However, this difference of LDL subfraction in hypertensive patients is associated with higher waist circumference, higher serum TG, older age and more statin usage. This result suggests that HTN may contribute to atherosclerosis and endothelial dysfunction with associated risk factors that influence LDL size.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM . Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917–1921.

    Article  CAS  PubMed  Google Scholar 

  2. Scott MG, Diane B, Luther TC, Richard SC, Margo AD, Wm JH et al. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation 2002; 106: 3143–3421.

    Article  Google Scholar 

  3. Austin MA, King MC, Vranizan KM, Krauss RM . Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495–506.

    Article  CAS  PubMed  Google Scholar 

  4. Campos H, Genest Jr JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12: 187–195.

    Article  CAS  PubMed  Google Scholar 

  5. Coresh J, Kwiterovich Jr PO, Smith HH, Bachorik PS . Association of plasma triglyceride concentration and ldl particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993; 34: 1687–1697.

    CAS  PubMed  Google Scholar 

  6. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (ldl) subfractions: relative contribution of small, dense ldl to coronary heart disease risk. Atherosclerosis 1994; 106: 241–253.

    Article  CAS  PubMed  Google Scholar 

  7. Gardner CD, Fortmann SP, Krauss RM . Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276: 875–881.

    Article  CAS  PubMed  Google Scholar 

  8. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882–888.

    Article  CAS  PubMed  Google Scholar 

  9. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the quebec cardiovascular study. Circulation 1997; 95: 69–75.

    Article  CAS  PubMed  Google Scholar 

  10. Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD et al. Relation of ldl size to the insulin resistance syndrome and coronary heart disease in american indians. The strong heart study. Arterioscler Thromb Vasc Biol 1997; 17: 2713–2720.

    Article  CAS  PubMed  Google Scholar 

  11. Nigon F, Lesnik P, Rouis M, Chapman MJ . Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular ldl receptor. J Lipid Res 1991; 32: 1741–1753.

    CAS  PubMed  Google Scholar 

  12. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J . Influence of plasma lipid and ldl-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996; 124: 261–271.

    Article  CAS  PubMed  Google Scholar 

  13. Vakkilainen J, Makimattila S, Seppala-Lindroos A, Vehkavaara S, Lahdenpera S, Groop PH et al. Endothelial dysfunction in men with small ldl particles. Circulation 2000; 102: 716–721.

    Article  CAS  PubMed  Google Scholar 

  14. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.

    Article  CAS  PubMed  Google Scholar 

  15. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.

    Article  PubMed  Google Scholar 

  16. Grundy SM . Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595–2600.

    Article  CAS  PubMed  Google Scholar 

  17. Alexander CM, Landsman PB, Teutsch SM, Haffner SM . NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among III NHANES participants age 50 years and older. Diabetes 2003; 52: 1210–1214.

    Article  CAS  PubMed  Google Scholar 

  18. Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PW et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the framingham heart study. Circulation 2006; 113: 20–29.

    Article  CAS  PubMed  Google Scholar 

  19. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J . Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990; 83 (1): 59–67.

    Article  CAS  PubMed  Google Scholar 

  20. Berneis K, Rizzo M . Does it matter? Swiss Med Wkly 2004; 134: 720–724.

    CAS  PubMed  Google Scholar 

  21. Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, Reitz RE . et al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol 2009; 29: 1975–1980.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Berneis KK, Krauss RM . Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43: 1363–1379.

    Article  CAS  PubMed  Google Scholar 

  23. Sacks FM, Campos H . Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 2003; 88: 4525–4532.

    Article  CAS  PubMed  Google Scholar 

  24. Ip S, Lichtenstein AH, Chung M, Lau J, Balk EM . Systematic review: association of low density lipoprotein subfractions with cardiovascular outcomes. Ann Intern Med 2009; 150: 474–484.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Chung M, Lichtenstein AH, Ip S, Lau J, Balk EM . Comparability of methods for LDL subfraction determination: a systematic review. Atherosclerosis 2009; 205: 342–348.

    Article  CAS  PubMed  Google Scholar 

  26. Frohlich J, Steiner G . Dyslipidaemia and coagulation defects of insulin resistance. Int J Clin Pract Suppl 2000; 113: 14–22.

    CAS  Google Scholar 

  27. Verges B . Diabetic dyslipidaemia: insights for optimizing patient management. Curr Med Res Opin 2005; 21 Suppl 1: S29–S40.

    Article  CAS  PubMed  Google Scholar 

  28. Kakafika AI, Liberopoulos EN, Karagiannis A, Athyros VG, Mikhailidis DP . Dyslipidaemia, hypercoagulability and the metabolic syndrome. Curr Vasc Pharmacol 2006; 4: 175–183.

    Article  CAS  PubMed  Google Scholar 

  29. Goff Jr DC, D’Agostino Jr RB, Haffner SM, Otvos JD . Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the insulin resistance atherosclerosis study. Metabolism 2005; 54: 264–270.

    Article  CAS  PubMed  Google Scholar 

  30. Miller WM, Nori-Janosz KE, Lillystone M, Yanez J, McCullough PA . Obesity and lipids. Curr Cardiol Rep 2005; 7: 465–470.

    Article  PubMed  Google Scholar 

  31. Landray MJ, Edmunds E, Li-Saw-Hee FL, Hughes BA, Beevers DG, Kendall MJ et al. Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension. QJM 2002; 95: 165–171.

    Article  CAS  PubMed  Google Scholar 

  32. Winkler K, Konrad T, Fullert S, Friedrich I, Destani R, Baumstark MW et al. Pioglitazone reduces atherogenic dense ldl particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. Diabetes Care 2003; 26: 2588–2594.

    Article  CAS  PubMed  Google Scholar 

  33. Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY . Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment. Hypertension 2003; 41: 528–533.

    Article  CAS  PubMed  Google Scholar 

  34. Choi CU, Seo HS, Lee EM, Shin SY, Choi E-J, Na JH et al. Statins do not decrease small, dense low-density lipoprotein. Tex Heart Inst J 2010; 37: 421–428.

    PubMed  PubMed Central  Google Scholar 

  35. Kim YJ, Williamson RA, Chen K, Smith JL, Murray JC, Merrill DC . Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia. Hypertension 2001; 38: 992–996.

    Article  CAS  PubMed  Google Scholar 

  36. Chen P, Jou YS, Fann CS, Chen JW, Chung CM, Lin CY et al. Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides. Hum Mutat 2009; 30: 49–55.

    Article  PubMed  Google Scholar 

  37. Espino-Montoro A, Barrios-Artillo M, Lopez-Chozas JM, Cayuela A, Stiefel P, Villar J . Influence of polymorphism (rflp-ssti) at the apolipoprotein c-iii gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism. Nutr Metab Cardiovasc Dis 2003; 13: 194–201.

    Article  CAS  PubMed  Google Scholar 

  38. Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F et al. Apolipoprotein c-iii, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 2003; 44: 2374–2381.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the Korea University Grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H S Seo.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, Y., Seo, H., Lee, E. et al. Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome. J Hum Hypertens 26, 670–676 (2012). https://doi.org/10.1038/jhh.2011.86

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2011.86

Keywords

This article is cited by

Search

Quick links